Impact of the EndoPredict-clin score on risk stratification in ER-positive, HER2-negative breast cancer after considering clinical guidelines.
Martin Filipits
Honoraria - Sividon Diagnostics GmbH
Peter Christian Dubsky
Honoraria - Sividon Diagnostics GmbH
Margaretha Rudas
Honoraria - Sividon Diagnostics GmbH
Jan C. Brase
Employment or Leadership Position - Sividon Diagnostics GmbH
Ralf Kronenwett
Employment or Leadership Position - Sividon Diagnostics GmbH
Karsten E. Weber
Employment or Leadership Position - Sividon Diagnostics GmbH
Christoph Petry
Employment or Leadership Position - Sividon Diagnostics GmbH
Marcus Schmidt
Honoraria - Sividon Diagnostics GmbH
Irmard Luisser
No relevant relationships to disclose
Evelyn Klug
No relevant relationships to disclose
Michael Gnant
No relevant relationships to disclose